These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 29190234)
1. FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY. van Dijk EHC; Schellevis RL; Breukink MB; Mohabati D; Dijkman G; Keunen JEE; Yzer S; den Hollander AI; Hoyng CB; de Jong EK; Boon CJF Retina; 2019 Feb; 39(2):398-407. PubMed ID: 29190234 [TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA). Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488 [TBL] [Abstract][Full Text] [Related]
3. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY. Dysli C; Berger L; Wolf S; Zinkernagel MS Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314 [TBL] [Abstract][Full Text] [Related]
4. TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY. Chung YR; Kim JW; Song JH; Park A; Kim MH Retina; 2019 Jan; 39(1):134-142. PubMed ID: 29077604 [TBL] [Abstract][Full Text] [Related]
5. Central Serous Chorioretinopathy. Daruich A; Matet A; Behar-Cohen F Dev Ophthalmol; 2017; 58():27-38. PubMed ID: 28351043 [TBL] [Abstract][Full Text] [Related]
6. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072 [TBL] [Abstract][Full Text] [Related]
7. OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy. Teussink MM; Breukink MB; van Grinsven MJ; Hoyng CB; Klevering BJ; Boon CJ; de Jong EK; Theelen T Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5229-37. PubMed ID: 26244299 [TBL] [Abstract][Full Text] [Related]
8. Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage. van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Blanco-Garavito R; Souied EH; MacLaren RE; Querques G; Fauser S; Hoyng CB; Downes SM; Boon CJF Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1419-1425. PubMed ID: 31123815 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy. Hanumunthadu D; Matet A; Rasheed MA; Goud A; Vuppurabina KK; Chhablani J Indian J Ophthalmol; 2019 Nov; 67(11):1850-1854. PubMed ID: 31638047 [TBL] [Abstract][Full Text] [Related]
10. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels. Çiloğlu E; Unal F; Dogan NC Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1111-1116. PubMed ID: 29671064 [TBL] [Abstract][Full Text] [Related]
11. Detection of Choroidal Neovascularization in Central Serous Chorioretinopathy Using Optical Coherence Tomographic Angiography. Weng S; Mao L; Yu S; Gong Y; Cheng L; Chen X Ophthalmologica; 2016; 236(2):114-21. PubMed ID: 27562525 [TBL] [Abstract][Full Text] [Related]
12. Ultra-wide field indocyanine green angiography in central serous chorioretinopathy. Akilesh MS; Kumar V; Sinha A; Azad S; Chawla R; Vohra R; Venkatesh P Indian J Ophthalmol; 2024 Jul; 72(Suppl 4):S606-S609. PubMed ID: 38770620 [TBL] [Abstract][Full Text] [Related]
13. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy. Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183 [TBL] [Abstract][Full Text] [Related]
14. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography. Azar G; Wolff B; Mauget-Faÿsse M; Rispoli M; Savastano MC; Lumbroso B Acta Ophthalmol; 2017 Jun; 95(4):421-427. PubMed ID: 27597633 [TBL] [Abstract][Full Text] [Related]
15. RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY. Matet A; Daruich A; Zola M; Behar-Cohen F Retina; 2018 Jul; 38(7):1403-1414. PubMed ID: 28570485 [TBL] [Abstract][Full Text] [Related]
16. Fundus autofluorescence findings in central serous chorioretinopathy using two different confocal scanning laser ophthalmoscopes: correlation with functional and structural status. Shin JY; Choi HJ; Lee J; Choi M; Chung B; Byeon SH Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1537-1544. PubMed ID: 26690973 [TBL] [Abstract][Full Text] [Related]
17. THE INCIDENCE OF NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Savastano MC; Rispoli M; Lumbroso B Retina; 2021 Feb; 41(2):302-308. PubMed ID: 32310626 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea. van Dijk EHC; Dijkman G; Boon CJF Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835 [TBL] [Abstract][Full Text] [Related]
19. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography. De Bats F; Cornut PL; Wolff B; Kodjikian L; Mauget-Faÿsse M Eur J Ophthalmol; 2018 Jul; 28(4):446-453. PubMed ID: 29554817 [TBL] [Abstract][Full Text] [Related]
20. Topography-guided identification of leakage point in central serous chorioretinopathy: a base for fluorescein angiography-free focal laser photocoagulation. Maltsev DS; Kulikov AN; Chhablani J Br J Ophthalmol; 2018 Sep; 102(9):1218-1225. PubMed ID: 29301768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]